Ignite Creation Date:
2024-10-25 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06553248
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-07
Brief Title:
A Trial Investigating the Safety Tolerability Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Clinical Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Multiple Doses of GZR4 in Chinese Patients With Type 2 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in China The aim of the trial is to investigate the safety tolerability pharmacokinetics and pharmacodynamics of mutiple-dose GZR4 in subjects with type 2 diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None